Impact of Drug Induced Long QT Syndrome: A Systematic Review

Abstract

BackgroundDrug induced long QT syndrome is quite common in daily clinical practice but its impact is unknown.MethodsPubMed and EMBASE databases (until May 2, 2017) were searched to identify studies reporting drug induced long QT syndrome and followed the PRISMA guidelines. The main outcomes measured in these studies were QTc prolongation, ventricular arrhythmias, torsade de pointes (TdP) and death.ResultsOut of 176 non-duplicate reports, 36 studies satisfied inclusion criteria and provided data on patients exposed to drugs that can potentially cause long QT. Totally, 14,756 patients were exposed and 930 patients (6.3%) were found to have QTc prolongation. The number of males was 6,400 and females were 5,723 patients. The mean age of the patients was 43.8 ± 9.36 years. Ventricular arrhythmias were found in 379 patients (2.6%), 26 patients were found to have premature atrial contractions (PACs) and premature ventricular contractions (PVCs). TdP was found in 49 patients (0.33 %), sudden cardiac death (SCD) was found in five patients and 586 patients were found to have all-cause mortality.ConclusionsAround 6% of patients have risk of QT prolongation when exposed but only 0.3% developed TdP and 2.6% developed ventricular arrhythmias. Risk of developing arrhythmias is higher with concomitant use of multiple QT prolonging drugs.

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors

“…Furthermore, in this study 1% of the patients had a prolonged QTc-interval (>470 ms). This prevalence is in line with other clinical findings and a recent investigation in cancer patients treated with conventional or targeted anti-cancer therapy (26,27).…”

Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy

“…The incidence of drug-induced LQTS/torsade de pointes is low, and it remains difficult to estimate an accurate incidence number since cases of torsade de pointes often are not recognized or are unreported [65,66]. In the MRS TM , the High-risk, drug-induced LQTS category corresponds to a score for drugs known to prolong the QT interval and associated with torsade de pointes.…”

COVID-19 Infection and Cardiovascular Diseases

“…COVID-19 enfeksiyonu tedavisinde hidroksiklorokin, azitromisin, lopinavir ve ritonavir yaygın olarak kullanılmaktadır (21) . (22,23) . Bu nedenle COVID-19 nedeniyle hidroksiklorokin başlanacak veya almakta olan hastalarda QT uzaması açısından risk değerlendirmesi (24) ve gereğinde kardiyoloji konsültasyonu yapılarak karar verilmesi gereklidir (Resim 1).…”